首页|柴枳平肝汤合消痞宽胃汤治疗肝胃不和型慢性胃炎的临床疗效

柴枳平肝汤合消痞宽胃汤治疗肝胃不和型慢性胃炎的临床疗效

扫码查看
目的 评估柴枳平肝汤合消痞宽胃汤治疗肝胃不和型慢性胃炎的临床疗效。方法 本研究为随机对照试验。纳入2020年1月至2023年4月期间陕西省核工业二一五医院收治的94例肝胃不和型慢性胃炎患者,采用分层随机抽样法分为研究组和对照组,每组47例。对照组男24例,女23例,年龄(44。81±5。62)岁,病程(2。60±1。35)年;研究组男23例,女24例,年龄(45。20±5。47)岁,病程(2。56±1。24)年。对照组接受标准的四联疗法,艾司奥美拉唑镁肠溶片、阿莫西林片、呋喃唑酮片和枸橼酸铋钾胶囊连续用药2周后,停止使用阿莫西林片、呋喃唑酮片和枸橼酸铋钾胶囊,继续服用艾司奥美拉唑镁肠溶片2周;研究组接受柴枳平肝汤合消痞宽胃汤治疗。两组疗程均为4周。对比两组患者临床疗效,中医症状积分,胃肠功能指标[生长抑素(SST)、胃泌素(GAS)、胃动素(MTL)、血管活性肠肽(VIP)]、炎性因子[白细胞介素-6(IL-6)、超敏C反应蛋白(hs-CRP)、肿瘤坏死因子(TNF-α)]水平,腹痛、反酸、嗳气消失时间,幽门螺杆菌(Hp)根除率。统计学方法采用t检验、x2检验。结果 研究组的临床治疗总有效率高于对照组[97。87%(46/47)比85。11%(40/47)],差异有统计学意义(x2=4。919,P=0。027)。治疗4周后,研究组中医症状积分总分为(3。70±0。53)分,对照组为(5。52±0。79)分,差异有统计学意义(t=13。116,P<0。001);研究组的 SST、GAS、MTL、VIP 水平分别为(299。60±20。18)ng/L、(81。38±6。15)ng/L、(51。60±6。28)ng/L、(22。35±2。79)ng/L,对照组分别为(200。19±17。96)ng/L、(70。18±5。62)ng/L、(43。57±5。65)ng/L、(26。16±4。15)ng/L,差异均有统计学意义(t=25。228、9。216、6。517、5。223,均P<0。001);研究组的 IL-6、hs-CRP、TNF-α 水平分别为(22。52±7。16)μg/L、(10。65±1。46)mg/L、(1。50±0。28)μg/L,均低于对照组的(35。51±7。74)μg/L、(15。88±2。18)mg/L、(1。94±0。34)μg/L,差异均有统计学意义(t=8。446、13。666、6。849,均P<0。001)。研究组患者的腹痛、反酸、嗳气消失时间分别为(3。57±2。02)d、(3。01±1。11)d、(3。47±1。33)d,对照组分别为(7。72±3。57)d、(8。07±3。64)d、(7。02±4。02)d,差异均有统计学意义(t=6。936、9。116、5。748,均P<0。001);停药30 d后,研究组的Hp根除率高于对照组[95。74%(45/47)比82。95%(39/47)],差异有统计学意义(x2=4。029,P=0。045)。结论 柴枳平肝汤合消痞宽胃汤治疗肝胃不和型慢性胃炎临床疗效显著,能有效改善患者的症状和生理指标,并提高Hp根除率,是一种安全且有效的治疗选择。
Clinical efficacy of Chai-Zhi Ping-Gan decoction combined with Xiao-Pi Kuan-Wei decoction in the treatment of liver-stomach disharmony type chronic gastritis
Objective To evaluate the clinical efficacy of Chai-Zhi Ping-Gan decoction combined with Xiao-Pi Kuan-Wei decoction in the treatment of liver-stomach disharmony type chronic gastritis.Methods A total of 94 patients with liver-stomach disharmony type chronic gastritis admitted to No.215 Hospital of Shaanxi Nuclear Industry from January 2020 to April 2023 were included and were divided into a study group and a control group by stratified random sampling method,with 47 cases in each group.In the control group,there were 24 males and 23 females,aged(44.81±5.62)years,with a duration of disease of(2.60±1.35)years.In the study group,there were 23 males and 24 females,aged(45.20±5.47)years,with a duration of disease of(2.56±1.24)years.The control group received standard quad therapy,esomeprazole magnesium enteric-coated tablets,amoxicillin tablets,furazolidone tablets,and bismuth potassium citrate capsules for 2 weeks,after stopping the use of amoxicillin tablets,furazolidone tablets,and bismuth potassium citrate capsules,and continued to take esomeprazole magnesium enteric-coated tablets for 2 weeks.The study group received Chai-Zhi Ping-Gan decoction combined with Xiao-Pi Kuan-Wei decoction treatment.The treatment course of both groups was 4 weeks.The clinical efficacy,traditional Chinese medicine(TCM)symptom score,gastrointestinal function indexes[somatostatin(SST),gastrin(GAS),motilin(MTL),and vasoactive intestinal peptide(VIP)],inflammatory markers[interleukin-6(IL-6),high-sensitivity C-reactive protein(hs-CRP),and tumor necrosis factor α(TNF-α)],disappearance time of abdominal pain,acid reflux,and belching,and eradication rate of Helicobacter pylori(Hp)of the two groups were compared.Statistical methods used were t test and x2 test.Results The total effective rate of clinical treatment in the study group was higher than that in the control group[97.87%(46/47)vs.85.11%(40/47)],with a statistically significant difference(x2=4.919,P=0.027).After 4 weeks of treatment,the total TCM symptom score in the study group was(3.70±0.53),and that in the control group was(5.52±0.79),with a statistically significant difference(t=13.116,P<0.001);the levels of SST,GAS,MTL,and VIP in the study group were(299.60±20.18)ng/L,(81.38±6.15)ng/L,(51.60±6.28)ng/L,and(22.35±2.79)ng/L,and those in the control group were(200.19±17.96)ng/L,(70.18±5.62)ng/L,(43.57±5.65)ng/L,and(26.16±4.15)ng/L,with statistically significant differences(t=25.228,9.216,6.517,and 5.223,all P<0.001);the levels of IL-6,hs-CRP,and TNF-α in the study group were(22.52±7.16)μg/L,(10.65±1.46)mg/L,and(1.50±0.28)μg/L,which were lower than those in the control group[(35.51±7.74)μg/L,(15.88±2.18)mg/L,and(1.94±0.34)μg/L],with statistically significant differences(t=8.446,13.666,and 6.849,all P<0.001).The disappearance time of abdominal pain,acid reflux,and belching in the study group were(3.57±2.02)d,(3.01±1.11)d,and(3.47±1.33)d,and those in the control group were(7.72±3.57)d,(8.07±3.64)d,and(7.02±4.02)d,with statistically significant differences(t=6.936,9.116,and 5.748,all P<0.001).Within 30 d after withdrawal,the eradication rate of Hp in the study group was higher than that in the control group[95.74%(45/47)vs.82.95%(39/47)],with a statistically significant difference(x2=4.029,P=0.045).Conclusion Chai-Zhi Ping-Gan decoction combined with Xiao-Pi Kuan-Wei decoction shows significant clinical efficacy in the treatment of liver-stomach disharmony type chronic gastritis,effectively improves the patients'symptoms and physiological indicators,and increases the Hp eradication rate,proving to be a safe and effective treatment choice.

Chronic gastritisLiver-stomach disharmony typeChai-Zhi Ping-Gan decoctionXiao-Pi Kuan-Wei decoctionGastrointestinal functionHp eradication rate

周彩彩、苏垠旭

展开 >

陕西省核工业二一五医院康复医学科,咸阳 712000

宝鸡市人民医院中医科,宝鸡 721000

慢性胃炎 肝胃不和型 柴枳平肝汤 消痞宽胃汤 胃肠功能 Hp根除率

陕西省自然科学基础研究计划

2021JQ-923

2024

国际医药卫生导报
中华医学会,国际医药卫生导报社

国际医药卫生导报

影响因子:0.781
ISSN:1007-1245
年,卷(期):2024.30(16)